xMAP® Technology

xMAP® Technology is a bead-based multiplexing platform that enables rapid detection of up to 500 analytes, including proteins or nucleic acids, from a small sample volume. The technology's sensitivity makes it ideal for complex serological applications. Luminex’s Partners have developed > 100 FDA 510(k)-cleared assays using xMAP Technology. Compared to ELISA, xMAP can shorten time to results, minimize the volume of sample required, and reduce labor by replacing multiple ELISAs with a single xMAP assay. xMAP is used in various diagnostic applications, including: • Genetically inherited disease screening • HLA typing and antibody testing for transplantation • Autoimmune disease profiling • Early cancer detection Luminex supports partners from concept to commercialization quickly through its unique expertise, end–to–end support, and access to thousands of labs using xMAP. Visit Luminex at Diasorin Booth #1431 to explore how you can collaborate with Luminex to accelerate your ass